-
Exogene raises $2 million for its AI platform to discover cell therapies for cancer
Oxford, UK, 25th April 2022 / Sciad Newswire / Exogene, a biotech company discovering novel T-cell receptor-based cell therapies, today announces that it has raised US$2 million in funding to develop its artificial intelligence (AI) platform for T-cell receptor discovery. T-cell receptor-based cell therapies are promising, curative treatments for otherwise untreatable advanced solid tumours. They consist of immune cells, known…
-
Rousselot Biomedical announces the world’s first GelMA produced under GMP
Irving, United States, 13th April 2022 / Sciad Newswire / Rousselot®, Darling Ingredients’ health brand, and the global leader of collagen-based solutions1 announces the launch of GMP grade GelMA. X-Pure® GelMA is the first gelatin methacryloyl, or GelMA, on the market to be produced under GMP conditions2. The production of X-Pure GelMA under GMP conditions is a major step forward…
-
Watson-Marlow Fluid Technology Solutions’ new name reflects strategy focused on delivering end-to-end fluid management solutions for customers
Falmouth, UK, 11 April 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Group – part of Spirax-Sarco Engineering plc, a FTSE 100 company – today announces it has changed its name to Watson-Marlow Fluid Technology Solutions (WMFTS). As the company evolves to meet the needs of the sectors in which it operates, following a successful period of global growth,…
-
Pfizer to Acquire ReViral and its Respiratory Syncytial Virus Therapeutic Candidates
Proposed acquisition strengthens Pfizer’s capabilities in infectious disease research and development with a complementary strategy to help improve patient outcomes through treatment for respiratory syncytial virus (RSV) infections and prevent illness through vaccination Expands Pfizer’s innovative anti-infective pipeline and utilizes the company’s R&D, manufacturing and commercialization expertise with the goal of addressing a significant unmet…
-
Novel drug from Neuro-Bio effective in a mouse model of Alzheimer’s Disease
Oxford, UK, 6th April 2022 / Sciad Newswire / Neuro-Bio Ltd, a biotechnology company developing a first-in-class treatment for neurodegenerative disease, finds its new drug candidate effectively treats the signs of neurodegeneration in a mouse model of Alzheimer’s disease. Publishing their work in Alzheimer’s & Dementia: Translational Research & Clinical Interventions (TRCI), Neuro-Bio researchers, in collaboration with the drug discovery…
-
We are Watson-Marlow: Daniel Rutter’s Apprenticeship Journey
Before starting my Apprenticeship, I studied at Falmouth Secondary School. During this time, I enjoyed subjects like P.E., physics, engineering and media studies – mainly because they really suited my learning style of observing a process then getting involved and doing it. At school, I really struggled with both my confidence and my dyslexia, which…
-
Easyfairs opens registration for new Connect in Pharma event
New Geneva-based event is set to bring together innovators in pharma packaging, devices and processing. London, United Kingdom, 22nd March 2022 / Sciad Newswire / Leading international events company Easyfairs today opens online registration for Connect in Pharma, the new event for the European pharma and biopharma community. The first edition of the event, taking place on 14 &…
-
ProteoGenix Launches New XtenCHO Transient CHO Expression System to Improve Biologics Development
New CHO system offers ten times higher yields, optimised plasmid stability and smart protocols with less hands-on time Schiltigheim, France, 15th March 2022 / Sciad Newswire / ProteoGenix, a contract research organization specialized in biologics discovery and bioproduction, announces the launch of its XtenCHOTM Transient Expression System. Due to its enhanced plasmid stability and optimized metabolism, the new proprietary…
-
Watson-Marlow Fluid Technology Group drives growth with new Operations and Supply Director
Abdul Butt joins Watson-Marlow as Operations and Supply Director Abdul will be responsible for driving the company’s supply excellence and enabling continued growth He becomes part of the executive team and reports directly to the group’s Managing Director, Andrew Mines Falmouth, United Kingdom, 10th March 2022 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG) is pleased to announce the appointment…
-
NanoSyrinx appoints R&D industry leader Dr Marie McAvoy as Chief Scientific Officer
Coventry, United Kingdom, 10th March 2022 / Sciad Newswire / NanoSyrinx, a biotech company using synthetic biology approaches to develop a new modality for the targeted intracellular delivery of biologic therapeutics, has strengthened its management team with the appointment of Dr Marie McAvoy as its Chief Scientific Officer. Dr McAvoy joins NanoSyrinx from GSK where she was Senior Director…